BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 27914211)

  • 1. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.
    Schulte C; Westermann D; Blankenberg S; Zeller T
    World J Cardiol; 2015 Dec; 7(12):843-60. PubMed ID: 26730290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
    Li M; Zhang J
    Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.
    Tijsen AJ; Pinto YM; Creemers EE
    Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1085-95. PubMed ID: 22942181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: Emerging biomarkers for atrial fibrillation.
    Komal S; Yin JJ; Wang SH; Huang CZ; Tao HL; Dong JZ; Han SN; Zhang LR
    J Cardiol; 2019 Dec; 74(6):475-482. PubMed ID: 31324570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and Cardiovascular Disease Risk.
    Searles CD
    Curr Cardiol Rep; 2024 Feb; 26(2):51-60. PubMed ID: 38206553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
    Schulte C; Zeller T
    Cardiovasc Diagn Ther; 2015 Feb; 5(1):17-36. PubMed ID: 25774345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as biomarkers of atrial fibrillation.
    Gomes da Silva AM; Silbiger VN
    Biomarkers; 2014 Dec; 19(8):631-6. PubMed ID: 25171770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.
    Esplugas R; Arenas M; Serra N; Bellés M; Bonet M; Gascón M; Vallvé JC; Linares V
    PLoS One; 2019; 14(5):e0217443. PubMed ID: 31150454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.
    da Silva AM; de Araújo JN; de Freitas RC; Silbiger VN
    Biomed Res Int; 2017; 2017():7804763. PubMed ID: 28349066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.